Pro Health Tips
Saturday, 28 November 2020
FDA Approves the First Drug to Treat an Rare Genetic Disorder Which Causes Kidney Stones
FDA has approved lumasiran subcutaneous injection to treat adults and children with primary hyperoxaluria type 1 (PH1)- an ultra- rare genetic disorder.
from Medindia Health News https://ift.tt/37jEkI1
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
FDA has approved lumasiran subcutaneous injection to treat adults and children with primary hyperoxaluria type 1 (PH1)- an ultra- rare genetic disorder.
No comments:
Post a Comment